Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maxim, Matyashin"'
Autor:
Pratibha Bhai, Benjamin Chin-Yee, Victor Pope, Ian Cheong, Maxim Matyashin, Michael A. Levy, Aidin Foroutan, Alan Stuart, Cyrus C. Hsia, Hanxin Lin, Bekim Sadikovic, Ian Chin-Yee
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7209-7217 (2022)
Background: Since the identification of JAK2 V617F and exon 12 mutations as driver mutations in polycythemia vera (PV) in 2005, molecular testing of these mutations for patients with erythrocytosis has become a routine clinical practice. However, the
Externí odkaz:
https://doaj.org/article/3f897fc6e5724f84ae1912b24b087ec4
Autor:
Benjamin, Chin-Yee, Maxim, Matyashin, Ian, Cheong, Pratibha, Bhai, Alejandro, Lazo-Langner, Ala, Almanaseer, Eri, Kawata, Michael A, Levy, Alan, Stuart, Hanxin, Lin, Ian, Chin-Yee, Bekim, Sadikovic, Cyrus, Hsia
Publikováno v:
CMAJ Open. 10:E988-E992
Molecular testing foriJAK2/imutations is part of the standard diagnostic workup for patients with suspected polycythemia vera. We sought to characterize evolving practice patterns in the investigation of erythrocytosis and the prevalence of secondary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4b41f38e07d15f15791ea24a2ce4b7
https://doi.org/10.9778/cmajo.20210322
https://doi.org/10.9778/cmajo.20210322
Autor:
Benjamin Chin-Yee, Pratibha Bhai, Ian Cheong, Maxim Matyashin, Cyrus C. Hsia, Eri Kawata, Jenny M. Ho, Michael A. Levy, Alan Stuart, Hanxin Lin, Ian Chin-Yee, Mike Kadour, Bekim Sadikovic, Alejandro Lazo-Langner
Publikováno v:
Journal of General Internal Medicine.
Erythrocytosis, most often measured as an increase in hemoglobin and/or hematocrit, is a common reason for referral to internal medicine and hematology clinics and a rational approach is required to effectively identify patients with polycythemia ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a3e567424d1468902ee7fd8912e7073
https://doi.org/10.1007/s11606-022-07963-x
https://doi.org/10.1007/s11606-022-07963-x
Autor:
Benjamin Chin‐Yee, Ian Cheong, Maxim Matyashin, Alejandro Lazo‐Langner, Ian Chin‐Yee, Vipin Bhayana, Pratibha Bhai, Hanxin Lin, Bekim Sadikovic, Cyrus C. Hsia
Publikováno v:
Paediatrics Publications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a84175e88120c32cab489c5839b989
https://ir.lib.uwo.ca/context/paedpub/article/3508/viewcontent/1161.pdf
https://ir.lib.uwo.ca/context/paedpub/article/3508/viewcontent/1161.pdf
Autor:
Maxim Matyashin, Ian Chin-Yee, Hanxin Lin, Alan Stuart, Sean Cuninghame, Bekim Sadikovic, Ian Cheong, Cyrus C. Hsia, Eri Kawata, Pratibha Bhai, Michael A. Levy, Benjamin Chin-Yee, Alejandro Lazo-Langner
Publikováno v:
Blood. 138:4630-4630
Background: Since the identification of JAK2 mutations in polycythemia vera (PV) in 2005 (Kralovics et al., NEJM 2005), molecular testing of JAK2 in patients with erythrocytosis has become part of routine clinical practice. We hypothesized that chang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd6bbde73e8287f78b1d24e38a7bf522
https://doi.org/10.1182/blood-2021-147626
https://doi.org/10.1182/blood-2021-147626
Autor:
Maxim Matyashin, Mike Kadour, Pratibha Bhai, Alejandro Lazo-Langner, Benjamin Chin-Yee, Eri Kawata, Bekim Sadikovic, Hanxin Lin, Ian Cheong, Ian Chin-Yee, Cyrus C. Hsia, Jenny M. Ho
Publikováno v:
Blood. 138:4635-4635
Background: The widespread availability of molecular testing for JAK2 mutations has facilitated the diagnosis of polycythemia vera (PV) but also raises the concern of test overutilization in patients referred for elevated hemoglobin. At our instituti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7795a878635e4e3fcc6c50b2d0d6dca
https://doi.org/10.1182/blood-2021-149241
https://doi.org/10.1182/blood-2021-149241
Autor:
Pratibha Bhai, Benjamin Chin-Yee, Ian Cheong, Maxim Matyashin, Michael A. Levy, Jenny Ho, Alejandro Lazo-Langner, Aidin Foroutan, Alan Stuart, Cyrus C. Hsia, Hanxin Lin, Ian Chin-Yee, Bekim Sadikovic
Publikováno v:
Blood. 138:2577-2577
Background: JAK2 V617F and exon 12 mutations are the characteristic driver mutations in polycythemia vera (PV), identified in more than 95% of patients. In addition, other genetic mutations have previously been described in JAK2-positive PV that appe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a75024a32daf9f6f566e9345643f2f7
https://doi.org/10.1182/blood-2021-148230
https://doi.org/10.1182/blood-2021-148230